These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7492638)

  • 21. The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase.
    Tan JC; Nocka K; Ray P; Traktman P; Besmer P
    Science; 1990 Jan; 247(4939):209-12. PubMed ID: 1688471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain.
    Jahn T; Seipel P; Coutinho S; Urschel S; Schwarz K; Miething C; Serve H; Peschel C; Duyster J
    Oncogene; 2002 Jul; 21(29):4508-20. PubMed ID: 12085229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts.
    Rygaard K; Nakamura T; Spang-Thomsen M
    Br J Cancer; 1993 Jan; 67(1):37-46. PubMed ID: 7678980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
    Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
    Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression, purification, and characterization of the first three immunoglobulin-like domains of human stem cell factor receptor].
    Su L; Liu CZ; Deng YC; Yang KG; Liang ZQ; Chen SS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):154-8. PubMed ID: 16733894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production and characterization of monoclonal antibodies that recognize bovine Kit receptor.
    Hikono H; Ohta M; Kubota T; Zhou JH; Inumaru S; Sakurai M
    Vet Immunol Immunopathol; 1999 May; 68(2-4):101-12. PubMed ID: 10438311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain.
    Yang CQ; Zhan X; Hu X; Kondepudi A; Perdue JF
    Endocrinology; 1996 Jul; 137(7):2766-73. PubMed ID: 8770896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
    Shivakrupa R; Bernstein A; Watring N; Linnekin D
    Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
    Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
    Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chicken macrophage stimulating protein is a ligand of the receptor protein-tyrosine kinase Sea.
    Wahl RC; Hsu RY; Huff JL; Jelinek MA; Chen K; Courchesne P; Patterson SD; Parsons JT; Welcher AA
    J Biol Chem; 1999 Sep; 274(37):26361-8. PubMed ID: 10473593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice.
    Duttlinger R; Manova K; Berrozpe G; Chu TY; DeLeon V; Timokhina I; Chaganti RS; Zelenetz AD; Bachvarova RF; Besmer P
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3754-8. PubMed ID: 7537375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.
    Vitali R; Cesi V; Nicotra MR; McDowell HP; Donfrancesco A; Mannarino O; Natali PG; Raschellà G; Dominici C
    Int J Cancer; 2003 Aug; 106(2):147-52. PubMed ID: 12800187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor.
    Wang H; Boussouar A; Mazelin L; Tauszig-Delamasure S; Sun Y; Goldschneider D; Paradisi A; Mehlen P
    Mol Cell; 2018 Nov; 72(3):413-425.e5. PubMed ID: 30293784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of interferon action: autoregulation of RNA-dependent P1/eIF-2 alpha protein kinase (PKR) expression in transfected mammalian cells.
    Thomis DC; Samuel CE
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10837-41. PubMed ID: 1279695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase.
    Lev S; Givol D; Yarden Y
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):678-82. PubMed ID: 1370584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction and functional cooperation between the serine/threonine kinase bone morphogenetic protein type II receptor with the tyrosine kinase stem cell factor receptor.
    Hassel S; Yakymovych M; Hellman U; Rönnstrand L; Knaus P; Souchelnytskyi S
    J Cell Physiol; 2006 Feb; 206(2):457-67. PubMed ID: 16155937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the promoter of the proto-oncogene c-kit.
    Chu TY; Besmer P
    Proc Natl Sci Counc Repub China B; 1995 Jan; 19(1):8-18. PubMed ID: 7539532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HEMCAM, an adhesion molecule expressed by c-kit+ hemopoietic progenitors.
    Vainio O; Dunon D; Aïssi F; Dangy JP; McNagny KM; Imhof BA
    J Cell Biol; 1996 Dec; 135(6 Pt 1):1655-68. PubMed ID: 8978830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit.
    Matthews W; Jordan CT; Gavin M; Jenkins NA; Copeland NG; Lemischka IR
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9026-30. PubMed ID: 1717995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bis(1H-2-indolyl)-1-methanones as inhibitors of the hematopoietic tyrosine kinase Flt3.
    Teller S; Krämer D; Böhmer SA; Tse KF; Small D; Mahboobi S; Wallrapp C; Beckers T; Kratz-Albers K; Schwäble J; Serve H; Böhmer FD
    Leukemia; 2002 Aug; 16(8):1528-34. PubMed ID: 12145694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.